Navigation Links
Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
Date:9/13/2011

SAN DIEGO, Sept. 13, 2011 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the UBS Global Life Sciences Conference in New York.  

The live presentation takes place on Tuesday, September 20, 2011 at 9:00 a.m. Eastern Time / 6:00 a.m. Pacific Time.  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, stress-related disorders, tardive dyskinesia, uterine fibroids, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Neurocrine Biosciences Announces the Start of Phase II Study of Elagolix in Uterine Fibroids
2. Neurocrine Biosciences To Present at the Stifel Nicolaus 2011 Healthcare Conference
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2011 Financial Results
4. Neurocrine Biosciences Announces elagolix Scientific Presentations at the 11th World Congress on Endometriosis
5. Neurocrine Biosciences to Present at the Jefferies 2011 Global Healthcare Conference
6. Neurocrine Biosciences to Present at the Deutsche Bank 36th Annual Healthcare Conference
7. Neurocrine Biosciences to Present at the 10th Annual Needham Healthcare Conference
8. Neurocrine Biosciences to Present at the Roth 23rd Annual OC Growth Stock Conference
9. Neurocrine Biosciences to Present at Citis 2011 Global Health Care Conference
10. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2010 Financial Results
11. Neurocrine Biosciences Reports Third Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... and BOCA RATON, Fla. , ... for the Commercialization of Public Research (the ... a funding agreement SegAna, LLC, an ... University of Central Florida. The Florida Institute supports ... bridges early funding gaps for companies spinning out ...
(Date:12/5/2016)... , Dec. 5, 2016  Breckenridge Pharmaceutical, Inc. ... multi-product marketing agreement with development and manufacturing partner ... Under the terms of this agreement, Breckenridge will ... in the United States . ... tentatively-approved ANDA. The products cover a wide range ...
(Date:12/5/2016)... , Dec. 5, 2016  Sharn Anesthesia Inc. ... anesthesia sales and distribution partner for Salter Labs.  The ... the Year in recognition of outstanding sales performance. ... for respiratory and anesthesia care, including the market gold ... also the master distributor of the Parker Flex-Tip® Endotracheal ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... December 06, 2016 , ... The Behavioral Health Center of ... the organization as a top behavioral service provider in the country. The award ... staff satisfaction and qualifications, and consumer satisfaction. These areas are measured via a ...
(Date:12/6/2016)... ... 2016 , ... Gateway Analytical, one of the world’s most ... sizing services for USP 788 and 789 particulate standards compliance. The new service ... to the needs of pharmaceutical and medical device manufacturers, who are required to ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... when SevenPoint2 released the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder ... one of the world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water ...
(Date:12/6/2016)... ... December 06, 2016 , ... Specialty Technical Publishers (STP) ... Audit Protocol Consortium (IAPC) EHS audit protocol for Great Britain . Leading ... of their EHS regulatory obligations and rapidly collect, share, archive, and export audit ...
(Date:12/6/2016)... ... 06, 2016 , ... U.S. Security Associates (USA) was named ... their industry leading training methods that engage their associates and link their achievements ... elite in employer-sponsored training and development programs. , “The 2017 Training Top 125 ...
Breaking Medicine News(10 mins):